Insulin analogue therapy in pregnancies complicated by diabetes mellitus

Expert Opinion on Pharmacotherapy

Volumn 6, Issue 5, 2005, Pages 735-742

  González, Claudio ^a,b   Santoro, Silvina ^a   Salzberg, Susana ^c   Di Girolamo, Guillermo ^a,d   Alvariñas, Jorge ^e  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NOVO NORDISK A S   (Denmark)

^c HOSPITAL DURAND   (Argentina)

^d Policlínico Bancario ^*  (Argentina)

^e Policlinico Bancario   (Argentina)

Author keywords

Diabetes; Gestational diabetes mellitus (DM); Insulin analogues; Insulin aspart; Insulin lispro; Pregnancy

Indexed keywords

CARBOHYDRATE; GLIBENCLAMIDE; GLUCOSE; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; PROTAMINE; SOMATOMEDIN C RECEPTOR;

BIRTH INJURY; CARBOHYDRATE INTOLERANCE; CLINICAL TRIAL; CONGENITAL MALFORMATION; DIABETES CONTROL; DIABETIC RETINOPATHY; DISEASE SEVERITY; DRUG ABSORPTION; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; FEMALE; HUMAN; HYPERBILIRUBINEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPOCALCEMIA; HYPOGLYCEMIA; INSULIN PUMP; INSULIN RELEASE; JAUNDICE; KIDNEY DISEASE; MACROSOMIA; MITOGENESIS; ORAL GLUCOSE TOLERANCE TEST; OUTCOMES RESEARCH; OVARY POLYCYSTIC DISEASE; PLACENTAL TRANSFER; POLYCYTHEMIA; POSTPRANDIAL STATE; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY TOXEMIA; PREMATURE LABOR; REVIEW; RISK ASSESSMENT; RISK REDUCTION; STRUCTURE ANALYSIS; TERATOGENICITY; URINARY TRACT INFECTION;

DIABETES, GESTATIONAL; FEMALE; FETAL DISEASES; HUMANS; INSULIN; MATERNAL WELFARE; PREGNANCY; PREGNANCY OUTCOME;

EID: 19044371344     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.6.5.735     Document Type: Review

References (44)

1. BLOOMGARDEN ZT: American Diabetes Association 60th Scientific Sessions, 2000. Diabetes Care (2000) 11:1699-1703.
2. AMERICAN DIABETES ASSOCIATION STATEMENT ON GESTATIONAL DIABETES MELLITUS: Diabetes Care (2004) 27(Suppl. 1):88-90.
3. GARG SK, FRIAS JP, ANIL S et al.: Insulin lispro therapy in pregnancies complicated by Type 1 diabetes: glycemic control and maternal and fetal outcomes. Endocrine Pract. (2003) 9:187-193.
4. BRAUNSTEIN GD: Endocrine changes in pregnancy. In: Williams textbook of Endocrinology (10th edition). Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (Eds), W.B. Saunders, Philadelphia (2002) 795-810.
5. CYPRYC K, SOBCZAK M, MARCZEWSKA M et al.: Pregnancy complications and perinatal outcomes in diabetic women treated with humalog (insulin lispro) or regular insulin during pregnancy. Med. Sci. Monit. (2004) 10(2):PI29-P32.
6. CASSON IF, CLARKE CA, HOWARD CV et al.: Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. Br. Med. J. (1997) 315(7130):275-278.
7. ABERG A, WESTBOM L, KALLEN B: Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum. Dev. (2001) 61(2):85-89.
8. CUNDY T, GAMBLE G, TOWNEND K et al.: Perinatal mortality in Type 2 diabetes mellitus. Diabet. Med. (2000) 17(1):33-39.
9. ORSKOU J, KESMODEL U, HENRIKSEN TB et al.: An increasing proportion of infants weight more than 4000 grams at birth. Acta. Obstet. Scand. (2001) 80(10):931-936.
10. RAYCHAUDHURI K, MARESH MJ: Glycemic control throughout pregnancy and fetal growth in insulin dependent diabetes. Obstet. Gynecol. (2000) 95(2):190-194.
11. COMBS CA, GUNDERSON E, KITZMILLER JL: Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care (1992) 15(10):1251-1257.
12. MANDERSON JG, PATTERSON CC, HADDEN DR et al.: Preprandial versus postprandial blood glucose monitoring in Type 1 diabetic pregnancy: a randomized controlled clinical trial. Am. J. Obstet. Gynecol. (2003) 189(2):507-512.
13. PARFITT VJ, CLARK JD, TURNER GM et al.: Maternal postprandial blood glucose levels influence infant birth weight in diabetic pregnancy. Diabetes Res. (1992) 19(3):133-135.
14. SIMMONS VD: The utility and efficacy of the new insulins in the management of diabetes and pregnancy. Curr. Diab. Rep. (2002) 2(4):331-336.
15. BOLLI GB, MARCHI RD, PARK GD et al.: Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia (1999) 42:1151-1167.
16. Insulin pharmacology. In: Textbook of diabetes 2 (3rd edition). Pickup J, Williams G (Eds), Blackwell Publishing, Oxford (2003) 8-11.
17. SIEBENHOFFER A, PLANK J, BERGHOLD A et al.: Short acting insulin analogs versus regular human insulin in patients with diabetes mellitus. The Cochrane Database of Systematic Reviews (2004) Issue 4. Art. Number:CD003287.pub 3.DOI: 10.1002/14651858.CD003287.pub 3.
18. SIEBENHOFFER A, PLANK J, BERGHOLD A et al.: Meta-analysis of short acting insulin analogs in adults patients with Type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy. Diabetologia (2004) 47:1895-1905.
19. KURTZHALS P: Engineering predictability and protraction in a basal insulin analogue: the pharmacology of insulin detemir. Int. J. Obes. Relat. Metab. Disord. (2004) 28(Suppl. 2):S23-28.
20. HERMANSEN K, MADSBAD S, PERRILD H et al.: Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in Type 1 diabetic subjects on basal-bolus therapy. Diabetes Care (2001) 24(2):296-301.
21. NORMAN RJ, WANG JX, HAGUE W: Should we continue or stop insulin sensitizing drugs during pregnancy? Curr. Opin. Obstet. Gynecol. (2004) 16(3):245-250.
22. SIMMONS D, WALTERS BN, ROWAN JA et al.: Metformin therapy and diabetes in pregnancy. Med. J. Aust. (2004) 181(3):174-175.
23. GLUECK CJ, GOLDENBERG N, WANG P et al.: Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum. Reprod. (2004) 19(3):510-521.
24. MCCARTHY EA, WALKER SP, MCLACHLAN K et al.: Metformin in obstetric and gynecologic practice: a review. Obstet. Gynecol. Surv. (2004) 59(2):118-127.
25. GLUECK CJ, GOLDENBERG N, STREICHER P et al.: Metformin and gestational diabetes. Curr. Diab. Rep. (2003) 3(4):303-312.
26. PERSSON B, SWAHN ML, HJERTBERG R et al.: Insulin lispro therapy in pregnancies complicated by Type 1 diabetes mellitus. Diabetes Res. Clin. Pract. (2002) 58(2):115-121.
27. GAMSON K, CHIA S, JOVANOVIC L: The safety and efficacy of insulin analogs in pregnancy. J. Matern. Fetal Neonatal Med. (2004) 15:26-34.
28. VANHAVERBEKE G, MERTENS A, MATHIEU C: Diabetic management in high risk patients. Acta Clin. Belg. (2004) 59(4):173-181.
29. SIMMON D, THOMPSON CF, CONROY C et al.: Use of insulin pumps in pregnancies complicated by Type 2 diabetes and gestational diabetes in a multiethnic community. Diabetes Care. (2001) 24(12):2078-2082.
30. RENARD E, RAINGEARD I, BOULOT P et al.: Insulin therapy in Type 1 diabetes for and during pregnancy: by which means and for which objectives. Diabetes Metab. (2001) 27(4 Pt 2):S61-S66.
31. MECACCI F, CARIGNANI L, CIONI R et al.: Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women. Eur. J. Obstet. Gynecol. Reprod. Biol. (2003) 111(1):19-24.
32. MASSON EA, PATMORE JF, BRASH PD et al.: Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog). Diabet. Med. (2003) 20(1):46-50.
33. PETTITT DJ, OSPINA P, KOLACZYNSKI JW et al.: Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus. Diabetes Care (2003) 26(1):183-186.
34. PERSSON B, SWAHN ML, HJERTBERG R et al.: Insulin lispro therapy in pregnancies complicated by Type 1 diabetes mellitus. Diabetes Res. Clin. Pract. (2002) 58(2):115-121.
35. JOVANOVIC L, ILIC S, PETTITT DJ et al.: Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care (1999) 22:1422-1427.
36. KITZMILLER JL, MAIN E, WARD B et al.: Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy. Diabetes Care (1999) 22:874-876.
37. JOVANOVIC L: Retinopathy risk: what is responsible? Hormones, hyperglycemia, or humalog? Diabetes Care (1999) 22:846-848.
38. LOUKOVARRA S, IMMONEN I, TERAMO KA et al.: Progression of retinopathy during pregnancy in Type 2 diabetic women treated with insulin lispro. Diabetes Care (2003) 26:1193-1198.
39. MENON RK, COHEN RM, SPERLING MA et al.: Transplacental passage of insulin in pregnant women with insulin dependent diabetes mellitus. N. Engl. J. Med. (1992) 326(4):280.
40. BOSKOVIC R, FEIG DS, DEREWLANY L et al.: Transfer of insulin lispro across the human placenta: in vitro perfusion studies. Diabetes Care (2003) 26(5):1390-1394.
41. KURTZHALS P, SCHAFFER L, KRISTENSEN C et al.: Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes (2000) 49:999-1005.
42. DIAMOND T, KORMAS N: Possible adverse fetal effect of insulin lispro. N. Engl. J. Med. (1997) 337:1009; author reply 1010.
43. ANDERSON H, BASTYR E, WISHNER K et al.: Letter to the Editor in response to 'Posible adverse fetal effect of insulin lispro'. N. Engl. J. Med. (1997) 337:1009-1010.
44. DE VECIANA M, MAJOR CA, MORGAN MA et al.: Posprandial versus preprandial blood glucose monitoring in woman with gestational diabetes mellitus requiring insulin therapy. N. Engl. J. Med. (1995) 333:1237-1241.